Frontlight ResearchEarly access
CompletedPhase 4
IMPACT OF LEVOTHYROXINE ON ERECTILE FUNCTION IN PATIENTS WITH HYPOTHYROIDISM
Key facts
- Who runs it
- Asociacion Instituto De Investigacion Sanitaria Biobizkaia
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 90 people enrolled
- Started
- 1 Oct 2024
- Ended
- 1 Dec 2025
- Type of study
- Interventional
- Record updated
- 23 December 2024
Who can take part
- Age
- 18 years and older
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Heterosexual males over 18 years of age
- Sexually active males
- Males diagnosed with HTs (TSH >5 with normal T4)
- Males with a diagnosis of ED according to the IIEF-15 questionnaire (score <25 points)
- Ability to complete the IIEF-15, EHS, PGIC and EDITS questionnaires
- Signature of informed consent
Who cannot take part
- Patients with pelvic radiotherapy (external or brachytherapy)
- Patients under active treatment for ED (phosphodiesterase 5 inhibitors, intraurethral or intracavernous alprostadil or with penile prosthesis placement)
- Contraindication for taking treatment with levothyroxine or sildenafil
- Presence of penile pathology that may explain the ED such as Peyronie's disease or hypospadias
- Patients with diagnosed neurological disease (Parkinson's, multiple sclerosis, spinal cord trauma, etc)
- Presence of endocrinological pathology that can explain the ED (analytical alteration of FSH, LH, progesterone, estradiol and/or testosterone hormones)
- Patients operated on pelvic organs with possible neurological involvement (radical prostatectomy, abdomino-perineal amputation, etc.)
- Patients with low sexual activity (<1 sexual encounter/15 days)
- Patient unable to complete the questionnaires
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To assess the impact on sexual activity of levothyroxine treatment (adjusted for weight (kg) and baseline TSH values) in patients with subclinical hypothyroidism (TSH >5) and erectile dysfunction as measured by the International Index of Erectile Function (IIEF-5), Erectile hardness score (EHS), Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) and Patient Global Impression of Change (PGIC) questionnaires
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Impact of levothyroxine on erectile function measured by the IIEF-15, EHS, PGIC and EDITS questionnaires in patients with hypothyroidism. Prospective, randomized controlled clinical trial with sildenafil 100
- Record updated
- 23 December 2024